Direkt zum Inhalt
Merck

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn's disease.

Nature communications (2020-04-15)
Lisa Mayr, Felix Grabherr, Julian Schwärzler, Isabelle Reitmeier, Felix Sommer, Thomas Gehmacher, Lukas Niederreiter, Gui-Wei He, Barbara Ruder, Kai T R Kunz, Piotr Tymoszuk, Richard Hilbe, David Haschka, Clemens Feistritzer, Romana R Gerner, Barbara Enrich, Nicole Przysiecki, Markus Seifert, Markus A Keller, Georg Oberhuber, Susanne Sprung, Qitao Ran, Robert Koch, Maria Effenberger, Ivan Tancevski, Heinz Zoller, Alexander R Moschen, Günter Weiss, Christoph Becker, Philip Rosenstiel, Arthur Kaser, Herbert Tilg, Timon E Adolph
ZUSAMMENFASSUNG

The increased incidence of inflammatory bowel disease (IBD) has become a global phenomenon that could be related to adoption of a Western life-style. Westernization of dietary habits is partly characterized by enrichment with the ω-6 polyunsaturated fatty acid (PUFA) arachidonic acid (AA), which entails risk for developing IBD. Glutathione peroxidase 4 (GPX4) protects against lipid peroxidation (LPO) and cell death termed ferroptosis. We report that small intestinal epithelial cells (IECs) in Crohn's disease (CD) exhibit impaired GPX4 activity and signs of LPO. PUFAs and specifically AA trigger a cytokine response of IECs which is restricted by GPX4. While GPX4 does not control AA metabolism, cytokine production is governed by similar mechanisms as ferroptosis. A PUFA-enriched Western diet triggers focal granuloma-like neutrophilic enteritis in mice that lack one allele of Gpx4 in IECs. Our study identifies dietary PUFAs as a trigger of GPX4-restricted mucosal inflammation phenocopying aspects of human CD.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
(±)-α-Tocopherol, synthetic, ≥96% (HPLC)
Sigma-Aldrich
Glutathion-Reduktase aus Backhefe (S. cerevisiae), ammonium sulfate suspension, 100-300 units/mg protein (biuret)
Sigma-Aldrich
Deferoxamin -mesylat (Salz), powder, ≥92.5% (TLC)
Sigma-Aldrich
β-Nicotinamidadenin-dinucleotidphosphat-2′-Phosphat, reduziert Tetranatriumsalz, ≥97% (HPLC)
Sigma-Aldrich
cis-4,7,10,13,16,19-Docosahexaensäure, ≥98%
Sigma-Aldrich
Cumolhydroperoxid, technical grade, 80%
Sigma-Aldrich
Anti-Aktin, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Ferrostatin-1, ≥95% (HPLC)
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Roche
In Situ Cell Death Detection-Kit, POD, sufficient for ≤50 tests
Sigma-Aldrich
Palmitoleinsäure, ≥98.5% (GC), liquid
Sigma-Aldrich
Palmitinsäure, BioXtra, ≥99%
Sigma-Aldrich
Arachidonsäure, >95.0% (GC)
Sigma-Aldrich
Arachidonsäure, from non-animal source, ≥98.5% (GC)
Sigma-Aldrich
Deoxycholsäure, ≥98% (HPLC)
Sigma-Aldrich
Ursodesoxycholsäure, ≥99%
Sigma-Aldrich
Lipopolysaccharide aus Escherichia coli O55:B5, purified by ion-exchange chromatography, TLR ligand tested
Sigma-Aldrich
cis-5,8,11,14,17-Eicosapentaensäure, ≥99%
Amersham Hybond® P Membranen für Western Blot, PVDF, pore size 0.45 μm, roll W × L 300 mm × 4 m, pkg of 1 ea
Sigma-Aldrich
Collagenase aus Clostridium histolyticum, 0.2 μm filtered, suitable for release of physiologically active rat hepatocytes, Type IV-S, 0.5-5.0 FALGPA units/mg solid, ≥125 CDU/mg solid
Sigma-Aldrich
L-Glutathion reduziert, ≥98.0%
Sigma-Aldrich
2-(Diisopropylamino)ethylmethacrylat, 97%, contains ~100 ppm monomethyl ether hydroquinone as inhibitor
Sigma-Aldrich
Oleinsäure, ≥99% (GC)
Sigma-Aldrich
allecis-7,10,13,16,19-Docosapentaensäure, synthetic, ≥97%
Sigma-Aldrich
ββ-Thujaplicin, 99%
Sigma-Aldrich
Natriumcholat Hydrat, suitable for cell culture, BioReagent
Sigma-Aldrich
Eisen(III)-Sulfat Hydrat, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Desoxyribonuklease II aus Rindermilz, Type V, essentially salt-free, lyophilized powder, ≥1,000 units/mg protein
Sigma-Aldrich
Bay 11-7082, ≥98% (HPLC), powder
Sigma-Aldrich
Stearidonsäure, ≥99%